Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apatinib Combined With IMRT for Thyroid Cancer
NCT03300765Phase 2Unknown
- Start
- Jul 2017
- Primary completion
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Rivoceranib in thyroid cancer. Status: unknown.
02
Drugs
Rivoceranib
03
Conditions
thyroid cancer
Beyond the preview
Go deeper on NCT03300765.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03300765.